British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized Covid-19 patients needing intensive care in a clinical trial.
The company said its nebulizer treatment produced a 79% lower risk of patients developing severe disease than those given a placebo in initial trials.
The company said its nebulizer treatment produced a 79% lower risk of patients developing severe disease than those given a placebo in initial trials, and patients that received the treatment "were more than twice as likely to recover over the course of the treatment period compared to those receiving placebo," Synairgen claimed.
The drug, SNG001, is a formulation of a naturally-occurring antiviral protein called interferon beta inhaled directly into the lungs, in the hope of stimulating an immune response. The treatment is aimed at preventing infected patients deteriorating from requiring oxygen to being placed on a ventilator.
"Our efforts are now focused on working with the regulators and other key groups to progress this potential Covid-19 treatment as rapidly as possible."
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'We really need help': Coronavirus overwhelms rural OregonThe coronavirus pandemic that's sweeping through major U.S. cities is now wreaking havoc on rural communities.
Read more »
Lying again about the pandemic, Trump made 200 false claims from early June to early JulyThe President's months-long bombardment of false and misleading claims about the virus and the pandemic, many of them egregious, continued from early June to early July
Read more »
Netanyahu's graft trial resumes amid Israeli virus angerJERUSALEM (AP) — Israeli Prime Minister Benjamin Netanyahu’s corruption trial resumed on Sunday, as the long-serving leader faces mounting discontent over his handling of the coronavirus...
Read more »
Congress confronts the next virus relief package as pandemic growsWith the coronavirus pandemic worsening, it’s clear that the $2.2 trillion coronavirus relief bill in March was only the start
Read more »
Netanyahu's corruption trial to hear first witnesses in JanuaryIsraeli Prime Minister Benjamin Netanyahu's corruption trial will begin in earnest in January with witnesses being heard three times a week, a court decided on Sunday.
Read more »